Advertisement
IQV vs OPK
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IQV is a Hold and OPK is a Hold.
Momentum Indicator for IQV turns negative, indicating new downward trend
IQV saw its Momentum Indicator move below the 0 level on October 01, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 75 similar instances where the indicator turned negative. In 55 of the 75 cases, the stock moved further down in the following days. The odds of a decline are at 73%.
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IQV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 38 of 60 cases where IQV's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 63%.
Following a +1.29% 3-day Advance, the price is estimated to grow further. Considering data from situations where IQV advanced for three days, in 190 of 304 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
IQV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 111 of 227 cases where IQV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 49%.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 15 (best 1 - 100 worst), indicating outstanding price growth. IQV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 18 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 43 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.225) is normal, around the industry mean (72.578). P/E Ratio (33.703) is within average values for comparable stocks, (146.993). Projected Growth (PEG Ratio) (0.985) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.001) among similar stocks. P/S Ratio (2.693) is also within normal values, averaging (9.775).
The Tickeron Profit vs. Risk Rating rating for this company is 98 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IQV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.
OPK in -6.16% downward trend, falling for three consecutive days on October 08, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where OPK declined for three days, in 223 of 278 cases, the price declined further within the following month. The odds of a continued downward trend are 80%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OPK as a result. In 70 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.
The Moving Average Convergence Divergence Histogram (MACD) for OPK turned negative on September 25, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In 30 of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at 75%.
OPK moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for OPK crossed bearishly below the 50-day moving average on October 12, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 71%.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +3.59% 3-day Advance, the price is estimated to grow further. Considering data from situations where OPK advanced for three days, in 159 of 213 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
OPK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 107 of 147 cases where OPK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 73%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 47 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.027) is normal, around the industry mean (72.578). P/E Ratio (26.110) is within average values for comparable stocks, (146.993). Projected Growth (PEG Ratio) (0.270) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.001) among similar stocks. P/S Ratio (2.134) is also within normal values, averaging (9.775).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 54 (best 1 - 100 worst), indicating fairly steady price growth. OPK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OPK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.
IQV | OPK | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 75 | 74 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 65 Fair valued | 47 Fair valued | |
PROFIT vs RISK RATING 1..100 | 98 | 100 | |
SMR RATING 1..100 | 43 | 92 | |
PRICE GROWTH RATING 1..100 | 15 | 54 | |
P/E GROWTH RATING 1..100 | 18 | 98 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
OPK's Valuation (47) in the Biotechnology industry is in the same range as IQV (65) in the Servicestothe Health Industry industry. This means that OPK’s stock grew similarly to IQV’s over the last 12 months.
IQV's Profit vs Risk Rating (98) in the Servicestothe Health Industry industry is in the same range as OPK (100) in the Biotechnology industry. This means that IQV’s stock grew similarly to OPK’s over the last 12 months.
IQV's SMR Rating (43) in the Servicestothe Health Industry industry is somewhat better than the same rating for OPK (92) in the Biotechnology industry. This means that IQV’s stock grew somewhat faster than OPK’s over the last 12 months.
IQV's Price Growth Rating (15) in the Servicestothe Health Industry industry is somewhat better than the same rating for OPK (54) in the Biotechnology industry. This means that IQV’s stock grew somewhat faster than OPK’s over the last 12 months.
IQV's P/E Growth Rating (18) in the Servicestothe Health Industry industry is significantly better than the same rating for OPK (98) in the Biotechnology industry. This means that IQV’s stock grew significantly faster than OPK’s over the last 12 months.
| IQV | OPK | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 76% |
| Stochastic ODDS (%) | 1 day ago 63% | 1 day ago 80% |
| Momentum ODDS (%) | 1 day ago 73% | 1 day ago 76% |
| MACD ODDS (%) | N/A | 1 day ago 75% |
| TrendWeek ODDS (%) | 1 day ago 64% | 1 day ago 79% |
| TrendMonth ODDS (%) | 1 day ago 71% | 1 day ago 77% |
| Advances ODDS (%) | 3 days ago 63% | 23 days ago 75% |
| Declines ODDS (%) | 8 days ago 64% | 7 days ago 80% |
| BollingerBands ODDS (%) | 1 day ago 68% | 1 day ago 82% |
| Aroon ODDS (%) | 1 day ago 49% | 1 day ago 73% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
IQV’s FA Score shows that 2 FA rating(s) are green while OPK’s FA Score has 0 green FA rating(s).
- IQV’s FA Score: 2 green, 3 red.
- OPK’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
IQV’s TA Score shows that 4 TA indicator(s) are bullish while OPK’s TA Score has 5 bullish TA indicator(s).
- IQV’s TA Score: 4 bullish, 2 bearish.
- OPK’s TA Score: 5 bullish, 5 bearish.
Price Growth
IQV (@Medical Specialties) experienced а +0.27% price change this week, while OPK (@Medical Specialties) price change was -9.59% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -2.55%. For the same industry, the average monthly price growth was +0.69%, and the average quarterly price growth was +36.12%.
Reported Earning Dates
IQV is expected to report earnings on Oct 27, 2026.
OPK is expected to report earnings on Nov 11, 2026.
Industries' Descriptions
@Medical Specialties (-2.55% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
Advertisement
IQV and
Correlation & Price change
A.I.dvisor indicates that over the last year, IQV has been closely correlated with CRL. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if IQV jumps, then CRL could also see price increases.
| Ticker / NAME | Correlation To IQV | 1D Price Change % | ||
|---|---|---|---|---|
| IQV | 100% | -0.58% | ||
| CRL - IQV | 71% Closely correlated | -0.94% | ||
| TMO - IQV | 68% Closely correlated | +0.12% | ||
| RVTY - IQV | 60% Loosely correlated | -0.34% | ||
| A - IQV | 58% Loosely correlated | +0.16% | ||
| ICLR - IQV | 54% Loosely correlated | -0.04% | ||
More | ||||
OPK and
Correlation & Price change
A.I.dvisor indicates that over the last year, OPK has been loosely correlated with ICUI. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if OPK jumps, then ICUI could also see price increases.
| Ticker / NAME | Correlation To OPK | 1D Price Change % | ||
|---|---|---|---|---|
| OPK | 100% | -4.35% | ||
| ICUI - OPK | 41% Loosely correlated | -0.41% | ||
| CLPT - OPK | 39% Loosely correlated | -3.82% | ||
| CRL - OPK | 36% Loosely correlated | -0.94% | ||
| IQV - OPK | 36% Loosely correlated | -0.58% | ||
| UTMD - OPK | 36% Loosely correlated | +0.40% | ||
More | ||||